Obermatt
See Similar Stocks →

Azenta

NSQ:AZTA · US1143401024
Life Sciences Tools & ServicesMedium

360

35
EV / EBIT47
Price / Owner Earnings60
Owner Earnings Yield1
Dividend Yield1
Price/Sales58
EV / Gross Profit95
Price/Book83
Return on Capital46
Cash Return on Capital49
Return on Equity50
EBIT Margin43
Gross Profitability36
Accruals51
Owner Earnings Margin32
Sales growth22
Profit growth38
Reinvestment24
Price momentum54
Debt load81
Refinancing90
Debt Payback1
Liquidity23
Analyst ratings25
Opinion Changes50
Price Target Upside44
Market mood49
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Azenta doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded1994
Employees1,157
Websiteazenta.com
ISINUS1143401024
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
GeneticsProcess AutomationStorage ManagementHealth DiagnosticsElectronicsIndustrialLife ScienceManufacturingSemiconductorSoftware

Description

Azenta, Inc. provides a biological and chemical compound sample exploration and management solutions for the life sciences industry, globally. Leveraging the company’s in-house precision automation and cryogenics capabilities that it was then applyi…

Analysis

Middle-of-the-road

Azenta, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is tepid; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
12
2023202420252026

All-time high

41

Jan 2024

All-time low

12

Mar 2026

Average rank

27

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
58
42
33
25
Price/Earnings
14
4
4
1
Price/Book
83
79
73
47
Dividend Yield
1
1
1
1
Value (overall)
46
23
24
13

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Azenta with its peers
Cadence Design
NSQ:CDNS
34
CountryUSA
IndustrySoftware
SizeX-Large
Full Stock Analysis →
Twist Bioscience
NSQ:TWST
46
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Phreesia
NYQ:PHR
70
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
GeneDx
NSQ:WGS
6
CountryUSA
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Descartes Systems
TOR:DSG
80
CountryCanada
IndustrySoftware
SizeLarge
Full Stock Analysis →
Upland Software
NMQ:UPLD
43
CountryUSA
IndustrySoftware
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →